Post-approval studies (Phase 4)WithdrawnNCT03761953
What this trial is testing
Oritavancin for Staphylococcus Aureus Infections in Opioid Users
Who this might be right for
Staphylococcus Aureus BacteremiaStaphylococcus Aureus Endocarditis
University of Pennsylvania